Guardant Health

Discussion in 'Stocks' started by vanzandt, Mar 12, 2019.

  1. vanzandt



    Reported tonight. Decent quarter. Interesting company/technology, cancer detection etc. Up just over 250% since the IPO last October. It closed near $77 AH's.

    The technology aside, I only point this company out because it has come pretty far pretty fast. I always assume some relatively smart people priced the IPO at a fairly reasonable price and now its at 50X 2019 estimated revenue ($130M)... which is pretty pricey.

    Better yet... IPO lockup expires 04/02.

    For anyone that cares... it might be good for the short radar and a decent scalp on a pullback as the lockup expiration approaches. I assume this is cutting edge bio-tech... but a business is a business and 50X sales, a 250% run in 6 months, and an IPO lockup that expires in 2 weeks.... looks pretty ripe.
  2. vanzandt


    $85 open.
  3. smallfil


    Thanks. I will wait for the next low risk entry point. Do not want to chase it. Like the stockchart.
    vanzandt likes this.
  4. vanzandt


    Just be careful... big pharma is looking for acquisitions.